MARKET

AMPH

AMPH

Amphastar Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.78
+0.14
+0.71%
Opening 11:56 01/27 EST
OPEN
19.32
PREV CLOSE
19.64
HIGH
19.81
LOW
19.32
VOLUME
43.47K
TURNOVER
--
52 WEEK HIGH
25.43
52 WEEK LOW
16.71
MARKET CAP
928.43M
P/E (TTM)
18.99
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AMPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AMPH News

  • Can You Imagine How Amphastar Pharmaceuticals's (NASDAQ:AMPH) Shareholders Feel About The 54% Share Price Increase?
  • Simply Wall St..01/08 10:15
  • Here is What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH)
  • Insider Monkey.12/18/2019 00:19
  • Momenta to pay $35M to settle Tennessee antitrust case
  • seekingalpha.12/11/2019 03:01
  • Edited Transcript of AMPH earnings conference call or presentation 7-Nov-19 10:00pm GMT
  • Thomson Reuters StreetEvents.12/10/2019 22:46

More

Industry

Pharmaceuticals
-0.28%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About AMPH

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.
More

Webull offers Amphastar Pharmaceuticals Inc (AMPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.